CJC-1295 with DAC

ACTIVE HALF-LIFE 6-8 hours
CLASSIFICATION Peptide Hormone
DOSAGE 300 mcg/day
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Hilma Biocare
WAREHOUSE EU Warehouse 3
SUBSTANCE GHRH Peptide

Introducing CJC-1295 DAC, a groundbreaking peptide hormone first launched by the Canadian biotechnology company ConjuChem in 2005. Unlike traditional GHRP peptides, CJC-1295 DAC ensures a consistent and gradual release of growth hormone, effectively mimicking the body?s natural responses without causing sudden spikes in hormone levels. Just one injection can elevate hormone concentration by an astonishing 2-10 times over six days, making it a favorite among athletes looking to enhance their performance.

Athletes who incorporate CJC-1295 DAC into their regimen can experience remarkable benefits, including accelerated muscle growth, improved overall performance, and reduced body fat. This powerful peptide also boosts collagen production, promoting the strength of tendons and ligaments while enhancing overall health.

As a peptide, CJC-1295 DAC is designed to minimize the risk of adverse effects commonly linked with anabolic steroids. The most frequently reported side effects are mild, including occasional water retention and transient feelings of weakness.

CJC-1295 DAC delivers impressive results and can be safely stacked with other peptides, anabolic steroids (AAS), and human growth hormone (HGH) for maximized effectiveness.